Quest Partners LLC trimmed its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 10.3% during the third quarter, ...

On Friday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $140.14 which represents a slight increase of $3.15 or 2.30% from the prior close of $136.99. The stock opened at $137.77 ...

On Tuesday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $135 which represents a slight increase of $4.26 or 3.26% from the prior close of $130.74. The stock opened at $130.11 and ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

We expect the latest development to positively boost market sentiment toward ILMN stock. Illumina currently has a market capitalization of $20.74 billion. The company’s earnings in 2024 are ...

Baron Funds, an investment management firm, released its “Baron Global Advantage Fund” third quarter 2024 investor letter. A ...

Illumina, Inc. ILMN is expanding its TruSight Oncology portfolio with a new version of its flagship cancer research assay, currently under development. The TruSight Oncology 500 v2 (TSO 500 v2) to ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...